VIKING GLOBAL PERFORMANCE LLC

CIK 000113262511 companiesGREENWICH, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001132625

Recent Transactions

50 trades

Sale
APi Group Corp$APG
Common Stock
2024-06-17$38.15/sh−39,032→ 0 total
Sale
APi Group Corp$APG
Common Stock
2024-06-17$38.15/sh−1,912,750→ 0 total
Sale
APi Group Corp$APG
Common Stock
2024-03-05$34.25/sh−2,977,845→ 1,912,750 total
Sale
APi Group Corp$APG
Common Stock
2024-03-05$34.25/sh−60,772→ 39,032 total
Conversion
APi Group Corp$APG
5.5% Series B Perpetual Convertible Preferred Stock
2024-02-28−4,000→ 0 total
Other
APi Group Corp$APG
Common Stock
2024-02-28$36.90/sh−3,983,739→ 4,890,595 total
Conversion
APi Group Corp$APG
Common Stock
2024-02-28$24.60/sh+164,016→ 181,104 total
Other
APi Group Corp$APG
Common Stock
2024-02-28$36.90/sh−81,300→ 99,804 total
Conversion
APi Group Corp$APG
5.5% Series B Perpetual Convertible Preferred Stock
2024-02-28−196,000→ 0 total
Conversion
APi Group Corp$APG
Common Stock
2024-02-28$24.60/sh+8,036,862→ 8,874,334 total
Sale
APi Group Corp$APG
Common Stock
2024-01-02$31.30/sh−6,300,817→ 27,032,516 total
Sale
APi Group Corp$APG
Common Stock
2024-01-02$31.30/sh−3,983→ 17,088 total
Sale
APi Group Corp$APG
Common Stock
2024-01-02$31.30/sh−195,200→ 837,472 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-06-22$9.90/sh−5,236,006→ 30,303,871 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-06-22$9.90/sh−110,756→ 641,010 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-06-22$9.90/sh−2,226,195→ 12,884,307 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-06-22$9.90/sh−5,427,043→ 31,409,512 total
Purchase
APi Group Corp$APG
5.5% Series B Perpetual Convertible Preferred Stock
2022-01-03$1000.00/sh+4,000→ 4,000 total
Purchase
APi Group Corp$APG
5.5% Series B Perpetual Convertible Preferred Stock
2022-01-03$1000.00/sh+196,000→ 196,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-12-14$55.65/sh−1,000,000→ 29,993,708 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-11-11$49.52/sh−2,500,000→ 30,993,708 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2020-01-28$24.98/sh−4,912,899→ 33,493,708 total
Conversion
Adaptive Biotechnologies Corp$ADPT
Series D Preferred Stock
2019-07-01−18,908,945→ 0 total
Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2019-07-01+2,007,740→ 38,116,035 total
Purchase
Adaptive Biotechnologies Corp$ADPT
Common Stock
2019-07-01$20.00/sh+250,000→ 1,675,000 total
Conversion
Adaptive Biotechnologies Corp$ADPT
Series F Preferred Stock
2019-07-01−2,007,740→ 0 total
Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2019-07-01+15,524,350→ 36,108,295 total
Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2019-07-01+18,908,945→ 20,583,945 total
Conversion
Adaptive Biotechnologies Corp$ADPT
Series F-1 Preferred Stock
2019-07-01−290,572→ 0 total
Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2019-07-01+290,572→ 38,406,607 total
Conversion
Adaptive Biotechnologies Corp$ADPT
Series E Preferred Stock
2019-07-01−15,524,350→ 0 total
Purchase
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-06-27$17.00/sh+4,705,900→ 26,620,991 total
Conversion
BridgeBio Pharma, Inc.$BBIO
Series D Preferred Units
2019-06-27−50,446,451→ 0 total
Conversion
BridgeBio Pharma, Inc.$BBIO
Series C Preferred Units
2019-06-27−51,781,276→ 0 total
Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-06-27+11,736,137→ 11,736,137 total
Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-06-27+10,178,954→ 21,915,091 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-19$8.17/sh+4,957→ 22,860,013 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-18$8.21/sh+6,706→ 22,855,056 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-17$8.53/sh+6,541→ 22,848,350 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-14$7.91/sh+7,144→ 22,841,809 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-13$7.95/sh+7,367→ 22,834,665 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-12$8.30/sh+7,500→ 22,827,298 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-11$8.58/sh+7,189→ 22,819,798 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-10$8.35/sh+7,500→ 22,812,609 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-07$7.96/sh+6,649→ 22,805,109 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-06$8.00/sh+7,082→ 22,798,460 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-05$8.02/sh+6,540→ 22,791,378 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-04$7.59/sh+7,500→ 22,784,838 total
Purchase
Myovant Sciences Ltd.
Common Shares, $0.000017727 par value per share
2019-06-04$8.25/sh+2,424,242→ 40,765,599 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-03$7.71/sh+5,424→ 22,777,338 total

Companies

Recent Filings

Address

55 RAILROAD AVENUE

GREENWICH, CT, 06830

View on SEC.gov